About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 525 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 525 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 361-380 of 525 trials

Active not recruitingProton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerWe are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different external radiation treatments: IMRT or PBT.NCT01617161·Jacksonville, Florida and 12 others CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Individualized Amonafide to Treat Prostate CancerThe purpose of this study is to assess the safety and efficacy of Amonafide in men with androgen-independent prostate cancer, assigned to individualized doses of Amonafide based…NCT00087854·Los Angeles, California and 7 others

TerminatedStudy Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersThis is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following…NCT05588609·Whittier, California and 6 others

CompletedVaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRationale: Vaccines may make the body build an immune response to kill tumor cells. It is not yet known if vaccine therapy is effective for prostate cancer.NCT00005947·Duarte, California and 33 others

RecruitingA Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate cancer.NCT07103018·San Francisco, California and 12 others

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

TerminatedMitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)The purpose of this research study is to determine if the combination of mitoxantrone, prednisone and sorafenib will improve the time to progression of advanced stage metastatic…NCT00452387·La Verne, California and 9 others

RecruitingOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyThis is a Phase II/III study.NCT06780670·Scottsdale, Arizona and 92 others

Active not recruitingSpaceIT Hydrogel System for Perirectal SpacingTo evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.NCT06451614·Laguna Hills, California and 25 others

CompletedHigh-Dose Stereotactic Radiation for Prostate CancerThis clinical trial studies high-dose stereotactic body radiation therapy (SBRT) in treating patients with low-, intermediate-, or high-risk localized prostate cancer.NCT01664130·Cleveland, Ohio

CompletedHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT01546987·Birmingham, Alabama and 171 others

RecruitingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsThis is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of…NCT06784193·Gilbert, Arizona and 24 others

CompletedNAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsAfrican-Americans have disparately limited access to optimal cancer care.NCT05978232·Cleveland, Ohio

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

CompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerThe purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to…NCT03085095·Tucson, Arizona and 161 others

TerminatedTreatment Decision Analysis Model for Prostate Cancer: A Randomized TrialThis is a psychosocial/behavioral study and does not involve administration of any treatment or diagnostic procedures.NCT02024685·Cleveland, Ohio

CompletedExternal-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells.NCT00006365·Birmingham, Alabama and 253 others

RecruitingEvaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErThis study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk…NCT05948657·Los Angeles, California and 3 others

CompletedExercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate CancerThis study is being done to determine if patients receiving personalized exercise therapy (versus those who do not receive personalized exercise therapy) have improved quality of…NCT04556045·Cleveland, Ohio

PreviousPage 19 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma